NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
Clinical Trials
44 trialsNCT07142226 2026-03-18
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
CHA University
Recruiting
NCT07151118 2026-03-18
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
CHA University
Recruiting
NCT06789848 2026-02-27
Ligufalimab and Cadonilimab in Advanced Liver Cancers
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT04907643 2026-02-20
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
Phase NA Recruiting
NCT07146646 2026-02-19
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Case Comprehensive Cancer Center
Phase 2 Recruiting
NCT06548412 2026-01-20
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT07235007 2026-01-13
BRAVE
Aichi Medical University
Phase NA Recruiting
NCT07337850 2026-01-13
FAPi-2
Tata Memorial Centre
Recruiting
NCT06065371 2025-12-19
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Henry Ford Health System
Phase 1 Recruiting
NCT07282262 2025-12-15
An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06909188 2025-12-12
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Institute of Liver and Biliary Sciences, India
Recruiting
NCT06546969 2025-12-10
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
University of Maryland, Baltimore
Phase 1 Recruiting
NCT06564623 2025-12-05
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Recruiting
NCT07267078 2025-12-05
Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06001658 2025-12-03
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT06529718 2025-11-17
SEVILLA
UNICANCER
Phase 2 Recruiting
NCT06731998 2025-09-18
LapTAP
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase NA Recruiting
NCT06893380 2025-09-15
GENTIS
CHA University
Recruiting
NCT07159204 2025-09-08
PILOT-BTC
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT07156058 2025-09-04
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT05942807 2025-08-26
BABEL
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT06178445 2025-08-19
TRAP-BTC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Recruiting
NCT06375967 2025-07-29
CARPEGIEM
Hospital Universitari de Bellvitge
Phase NA Recruiting
NCT06653192 2025-07-29
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)
Hospital Universitari de Bellvitge
Phase NA Recruiting
NCT04935853 2025-07-23
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
GERCOR - Multidisciplinary Oncology Cooperative Group
Recruiting
NCT07062263 2025-07-14
TAB-2
Tata Memorial Centre
Phase 3 Recruiting
NCT05451043 2025-06-26
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
AHS Cancer Control Alberta
Phase 2 Recruiting
NCT07025174 2025-06-17
SAIB
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT05615818 2025-04-23
SAFIR-ABC10
UNICANCER
Phase 3 Recruiting
NCT06937567 2025-04-22
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT06214572 2025-04-11
RUGB
Tata Memorial Centre
Phase 2/3 Recruiting
NCT06620848 2025-04-02
A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
Shanghai Zhongshan Hospital
Phase 2 Recruiting
NCT06037980 2025-02-17
PURITY
Gruppo Oncologico del Nord-Ovest
Phase 2/3 Recruiting
NCT05520788 2025-02-11
CCGLC-006
Tongji Hospital
Recruiting
NCT06139042 2025-02-10
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
NCT05222971 2025-01-28
OPTIMUM
Asan Medical Center
Phase 2 Recruiting
NCT05517811 2025-01-28
TEG
University of Colorado, Denver
Recruiting
NCT06101277 2025-01-06
LIVELONG
University of California, Davis
Phase NA Recruiting
NCT06653127 2024-12-30
CCGLC-016
Tongji Hospital
Recruiting
NCT06060990 2024-10-17
Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT04318834 2024-04-17
COMPASS-B-MUHC
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Recruiting
NCT06320301 2024-03-20
Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT03482102 2022-09-08
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Massachusetts General Hospital
Phase 2 Recruiting